Affiliation:
1. Thyroid Unit, Endocrine Division, Hospital de Clínicas de Porto
Alegre, Porto Alegre, Rio Grande do Sul, Brazil
2. Nuclear Medicine, Hospital de Clínicas de Porto Alegre, Porto
Alegre, Rio Grande do Sul, Brazil
Abstract
AbstractInitial treatment for differentiated thyroid carcinoma (DTC) often consists of
surgery and the administration of radioiodine. In this context, post-treatment
Whole-Body Scans (ptWBS) are currently recommended, but data on its diagnostic
accuracy are rare. The aim of the study was to evaluate the performance of ptWBS
for distant metastasis in DTC patients. We included DTC patients who received
radioiodine and underwent ptWBS between 2009–2015. The medical data were
independently reviewed by two specialists to evaluate the concordance of
positive distant ptWBS uptake and distant metastasis documented by imaging exams
(gold standard). We studied 268 DTC patients. The mean age was 46±16
years (82% women), and papillary thyroid carcinoma was diagnosed in
87% of the patients. The median tumor size was 2.7 cm,
40% had lymph node involvement, and 11% had distant metastasis.
Twenty-eight patients (10%) had distant ptWBS uptake, and nine of them
(32%) were false-positives. In addition, nine false-negative ptWBS
uptakes were identified. The overall performance of ptWBS showed 68%
sensitivity and 96% specificity with significantly different performance
according to the American Thyroid Association (ATA) risk groups. While the ptWBS
performance for ATA low-intermediate-risk showed 29% sensitivity,
97% specificity, and Kappa of 0.19, the ATA high-risk group ptWBS
displayed high sensitivity (82%), specificity (100%), and good
agreement (Kappa 0.74). ptWBS is useful for a subgroup of ATA high-risk DTC
patients. The overall poor performance of ptWBS suggests that it should be
reconsidered for routine use in ATA at low to intermediate risk: the exam has
little value to this subgroup.
Funder
Conselho Nacional
de Desenvolvimento Científico e Tecnológico
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundo de Incentivo à Pesquisa
Programa de Apoio a Núcleos de Excelência (PRONEX)/Fundação de Amparo à Pesquisa do Estado
do Rio Grande do Sul
Subject
Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,General Medicine,Endocrinology, Diabetes and Metabolism
Reference30 articles.
1. Global cancer statistics: GLOBOCAN estimates of incidence and mortality
worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin,2018
2. 2015 American thyroid association management guidelines for adult patients with
thyroid nodules and differentiated thyroid cancer: The american thyroid
association guidelines task force on thyroid nodules and differentiated thyroid
cancer;B R Haugen;Thyroid
3. Sodium iodide symporter for nuclear molecular imaging and gene therapy: from
bedside to bench and back;B C Ahn;Theranostics,2012
4. Sodium iodide symporter: its role in nuclear medicine;J K Chung;J Nucl Med,2002
5. Outcome of differentiated thyroid cancer with detectable serum Tg and negative
diagnostic 131 I whole body scan: Comparison of patients treated with high 131 I
activities versus untreated patients;F Pacini;J Clin Endocrinol Metab,2001
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献